CFDE Data Portal | Search FRG2

	Label	Description
	FRG2 associations Collection (Entity type)	Associations for FRG2_associations
	FRG2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FRG2 Gene (Entity type)	ENSG00000205097 - FSHD region gene 2
	KFGENEBIN:FRG2-variant-count CUI gene has variants FRG2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Kids First
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE192771 2 V 3 SORAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE151612 4 V 2 PRACINOSTAT HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 2 V 14 TALAZOPARIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

FRG2 associations

Associations for FRG2_associations

FRG2 associations.tsv

A file from IDG as part of the Harmonizome project

FRG2

ENSG00000205097 - FSHD region gene 2

KFGENEBIN:FRG2-variant-count CUI gene has variants FRG2

A Knowledge Graph Assertion from Kids First

GSE195663 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE238213 dopamine 2 v 0 human up

A Gene Set from LINCS

GSE225869 3 V 0 TEMOZOLOMIDE HUMAN UP

A Gene Set from LINCS

GSE192771 2 V 3 SORAFENIB HUMAN UP

A Gene Set from LINCS

GSE151612 4 V 2 PRACINOSTAT HUMAN DN

A Gene Set from LINCS

GSE202434,GSE202438 2 V 14 TALAZOPARIB HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.